We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov Menu

Cardiovascular Prophylaxis for Postmenopausal Women

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified May 2009 by University of Leeds.
Recruitment status was:  Recruiting
ClinicalTrials.gov Identifier:
First Posted: October 13, 2010
Last Update Posted: October 28, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
University of Leeds
The purpose of this study was to examine the effect of 6 months moderate intensity exercise training completed three times per week upon traditional and emerging cardiovascular disease risk factors in postmenopausal women both with and without type 2 diabetes. These risk factors include blood markers associated with increased risk such as cholesterol, insulin, glucose and markers of inflammation plus measures of body fat, heart and lung fitness, vascular stiffness and vascular function. The study hypothesised that moderate intensity exercise training would intervene in the exaggerated risk seen in women following the menopause, especially in those with type 2 diabetes.

Condition Intervention Phase
Cardiovascular Disease Behavioral: Exercise training Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Prevention
Official Title: Can a Moderate Intensity Exercise Training Programme Improve Cardiac Function and Known Cardiovascular Risk Factors in Middle-aged Women?

Resource links provided by NLM:

Further study details as provided by University of Leeds:

Primary Outcome Measures:
  • Maximal oxygen uptake [ Time Frame: 6 months ]

Secondary Outcome Measures:
  • lipoprotein profile [ Time Frame: 6 months ]
  • Flow mediated dilation [ Time Frame: 6 months ]
  • Cardiac power output [ Time Frame: 6 months ]
  • Arterial stiffness [ Time Frame: 6 months ]
  • Inflammatory markers [ Time Frame: 6 months ]
  • Body composition [ Time Frame: 6 months ]

Estimated Enrollment: 100
Study Start Date: July 2005
Estimated Study Completion Date: December 2011
Estimated Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)
Intervention Details:
    Behavioral: Exercise training
    6 months of moderate intensity exercise training 3 times per week

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   45 Years to 65 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Healthy and stable type II diabetic postmenopausal women (cessation of menstrual periods for 12 months and confirmed with LH/FSH samples) aged 45 − 65 years old for the cross sectional analysis and exercise training study.

Exclusion Criteria:

  • Identified abnormalities during baseline testing.
  • Vigorously active women.
  • Women who are pregnant.
  • Women with serious systemic or psychological disorders (e.g. COPD, asthma, clinical depression).
  • Women with known coronary artery disease.
  • Women with significant cardiovascular pathologies and associated medication.
  • Women with type 1 or insulin treated diabetes.
  • Women with diabetes with complications.
  • Women with unstable diabetes or hypertension.
  • Women with any cancer.
  • Women with musculoskeletal impairments or contraindications to exercise.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01219725

Contact: Karen M Birch, BSc, PhD 44 11336713 k.m.birch@leeds.ac.uk

United Kingdom
Centre for Sports and Exercise Sciences, University of Leeds Recruiting
Leeds, West Yorkshire, United Kingdom, LS2 9JT
Principal Investigator: Karen M Birch, BSc, PhD         
Sponsors and Collaborators
University of Leeds
Principal Investigator: Karen M Birch, BSC, PhD University of Leeds
  More Information

Responsible Party: Dr Karen Michelle Birch, University of Leeds
ClinicalTrials.gov Identifier: NCT01219725     History of Changes
Other Study ID Numbers: RG2508/06/08
First Submitted: October 12, 2010
First Posted: October 13, 2010
Last Update Posted: October 28, 2010
Last Verified: May 2009

Keywords provided by University of Leeds:
Body composition
Endothelial function
Lipoprotein profile
Inflammatory markers
Aerobic capacity
Thrombotic markers
Arterial stiffness
Cardiac function
Traditional and emerging cardiovascular disease risk factors

Additional relevant MeSH terms:
Cardiovascular Diseases